Patient-Reported Symptoms and Mental Health Event Risks in Adolescents and Young Adults With Cancer

IF 3.1 2区 医学 Q2 ONCOLOGY
Cancer Medicine Pub Date : 2025-08-01 DOI:10.1002/cam4.71096
Sumit Gupta, Qing Li, Paul Nathan, Paul Kurdyak, Nancy Baxter, Rinku Sutradhar, Natalie Coburn
{"title":"Patient-Reported Symptoms and Mental Health Event Risks in Adolescents and Young Adults With Cancer","authors":"Sumit Gupta,&nbsp;Qing Li,&nbsp;Paul Nathan,&nbsp;Paul Kurdyak,&nbsp;Nancy Baxter,&nbsp;Rinku Sutradhar,&nbsp;Natalie Coburn","doi":"10.1002/cam4.71096","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Adolescents and young adults (AYA) with cancer are at risk of adverse mental health outcomes during and after treatment. Tools identifying AYA at the highest risk would guide screening and interventions. We determined whether self-reported symptoms following cancer diagnosis were associated with early and late severe mental health events (SMHEs).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Ontario AYA diagnosed with cancer aged 15–29 between 2010 and 2018 were identified and linked to healthcare databases, including one capturing self-reported Edmonton Symptom Assessment System (ESAS) scores at cancer-related visits. Scores for depression, anxiety, and poor well-being were categorized as not measured, mild, moderate, or severe. SMHEs were defined as mental health-related Emergency Department visits or hospitalizations. We determined the association of ESAS scores with subsequent early SMHEs (&lt; 5 years). Among 5-year survivors, we determined the association between the maximum ESAS score within 1 year of cancer diagnosis and late SMHEs (occurring &gt; 5 years from cancer diagnosis).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Among 5435 AYA, symptom severity was associated with subsequent SMHE risk. AYA who reported severe versus mild anxiety were at &gt; 3-fold higher risk of subsequent early SMHEs [adjusted hazard ratio (aHR) 3.6, 95th confidence interval (CI) 1.9–6.7; <i>p</i> &lt; 0.001]. Among 3518 (64.7%) 5-year survivors, symptom severity predicted late SMHE. At 5 years postcancer diagnosis, those who reported severe versus mild depression within 1 year following cancer diagnosis were at 3-fold elevated risk (aHR 3.0, 95 CI 1.8–4.9; <i>p</i> &lt; 0.0001).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Systematic symptom screening early postcancer diagnosis identifies AYA at high risk of both early and late SMHEs who may benefit from targeted screening and interventions.</p>\n </section>\n </div>","PeriodicalId":139,"journal":{"name":"Cancer Medicine","volume":"14 15","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.71096","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cam4.71096","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Adolescents and young adults (AYA) with cancer are at risk of adverse mental health outcomes during and after treatment. Tools identifying AYA at the highest risk would guide screening and interventions. We determined whether self-reported symptoms following cancer diagnosis were associated with early and late severe mental health events (SMHEs).

Methods

Ontario AYA diagnosed with cancer aged 15–29 between 2010 and 2018 were identified and linked to healthcare databases, including one capturing self-reported Edmonton Symptom Assessment System (ESAS) scores at cancer-related visits. Scores for depression, anxiety, and poor well-being were categorized as not measured, mild, moderate, or severe. SMHEs were defined as mental health-related Emergency Department visits or hospitalizations. We determined the association of ESAS scores with subsequent early SMHEs (< 5 years). Among 5-year survivors, we determined the association between the maximum ESAS score within 1 year of cancer diagnosis and late SMHEs (occurring > 5 years from cancer diagnosis).

Results

Among 5435 AYA, symptom severity was associated with subsequent SMHE risk. AYA who reported severe versus mild anxiety were at > 3-fold higher risk of subsequent early SMHEs [adjusted hazard ratio (aHR) 3.6, 95th confidence interval (CI) 1.9–6.7; p < 0.001]. Among 3518 (64.7%) 5-year survivors, symptom severity predicted late SMHE. At 5 years postcancer diagnosis, those who reported severe versus mild depression within 1 year following cancer diagnosis were at 3-fold elevated risk (aHR 3.0, 95 CI 1.8–4.9; p < 0.0001).

Conclusion

Systematic symptom screening early postcancer diagnosis identifies AYA at high risk of both early and late SMHEs who may benefit from targeted screening and interventions.

Abstract Image

青少年和青年癌症患者报告的症状和心理健康事件风险
患有癌症的青少年和年轻人(AYA)在治疗期间和治疗后面临不良心理健康结果的风险。识别AYA风险最高的工具将指导筛查和干预。我们确定癌症诊断后自我报告的症状是否与早期和晚期严重心理健康事件(SMHEs)相关。方法对2010年至2018年期间被诊断为癌症的15-29岁安大略省AYA患者进行识别,并将其与医疗数据库相关联,其中一个数据库捕获了癌症相关就诊时埃德蒙顿症状评估系统(ESAS)的自我报告评分。抑郁、焦虑和健康状况不佳的得分分为未测量、轻度、中度和重度。smhe被定义为与精神健康相关的急诊就诊或住院。我们确定了ESAS评分与随后的早期SMHEs(5年)的关系。在5年幸存者中,我们确定了癌症诊断1年内最高ESAS评分与晚期SMHEs(发生于癌症诊断后5年)之间的关系。结果在5435例AYA患者中,症状严重程度与随后的SMHE风险相关。报告重度焦虑与轻度焦虑的AYA患者随后发生早期SMHEs的风险高出3倍[调整风险比(aHR) 3.6,第95可信区间(CI) 1.9-6.7;p < 0.001]。在3518例(64.7%)5年幸存者中,症状严重程度预测晚期SMHE。在癌症诊断后5年,那些在癌症诊断后1年内报告严重抑郁和轻度抑郁的人的风险增加了3倍(aHR 3.0, 95 CI 1.8-4.9;p < 0.0001)。结论系统症状筛查早期癌后诊断可识别早期和晚期SMHEs高危AYA患者,可通过有针对性的筛查和干预措施获益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Medicine
Cancer Medicine ONCOLOGY-
CiteScore
5.50
自引率
2.50%
发文量
907
审稿时长
19 weeks
期刊介绍: Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas: Clinical Cancer Research Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations Cancer Biology: Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery. Cancer Prevention: Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach. Bioinformatics: Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers. Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信